Livongo Raises $52.5M to Expand Chronic Disease Management Platform

Digital health innovator Livongo has secured $52.5 million in a growth funding round led by General Catalyst and Kinnevik, with participation from Microsoft Ventures, EDBI, and American Investment Holdings. This latest investment brings Livongo’s total funding to $142 million since its 2014 launch.

Revolutionizing Chronic Condition Management

Livongo combines AI-driven technology with personalized coaching to help individuals manage chronic diseases like diabetes. Their flagship product includes:

  • A connected glucose meter that automatically uploads readings to the cloud
  • Real-time data analytics and insights
  • Personalized health coaching via mobile app

The platform serves both individual users and enterprise clients (employers and health plans) seeking to reduce healthcare costs through better chronic disease management.

Strategic Growth Plans

CEO Glen Tullman outlined three key priorities for the new funding:

  1. Enhance existing diabetes management tools
  2. Expand into additional chronic conditions (including hypertension)
  3. Launch international expansion later in 2017

“We’re focused on empowering members to live healthier lives, not just manage conditions,” Tullman emphasized. “This means addressing health comprehensively while improving outcomes and lowering costs.”

Digital Health Investment Boom

Livongo’s funding comes amid strong investor interest in digital health solutions:

  • Accolade raised $93.6M (August 2016) for employer healthcare cost reduction
  • Vida Health secured $18M (December 2016) for chronic disease coaching
  • Biomatics Capital Partners launched a $200M fund (March 2017) for health tech startups

“Livongo is one of our fastest-growing portfolio companies,” noted Hemant Taneja, Managing Director at General Catalyst. “We’re excited to support their market leadership expansion.”

Livongo Connected Health Platform Livongo’s connected health devices provide real-time monitoring and insights

With chronic diseases affecting 45% of Americans (CDC data), Livongo’s tech-enabled approach positions it at the forefront of a growing $46 billion digital health market.


📚 Featured Products & Recommendations

Discover our carefully selected products that complement this article’s topics:

🛍️ Featured Product 1: Star Trek: The Original Series Delta Adult Tank Top

Star Trek: The Original Series Delta Adult Tank Top Image: Premium product showcase

High-quality star trek: the original series delta adult tank top offering outstanding features and dependable results for various applications.

Key Features:

  • Industry-leading performance metrics
  • Versatile application capabilities
  • Robust build quality and materials
  • Satisfaction guarantee and warranty

🔗 View Product Details & Purchase


🛍️ Featured Product 2: Lindyn Fog 2-Piece RAF Sofa Chaise

Lindyn Fog 2-Piece RAF Sofa Chaise Image: Premium product showcase

Carefully crafted lindyn fog 2-piece raf sofa chaise delivering superior performance and lasting value.

Key Features:

  • Professional-grade quality standards
  • Easy setup and intuitive use
  • Durable construction for long-term value
  • Excellent customer support included

🔗 View Product Details & Purchase


🛍️ Featured Product 3: Broan 30″ 300 CFM Under-Cabinet Range Hood – White|Hotte de cuisinière sous l’armoire 300 pi3/min Broan de 30 po – blanche|BCS330WW

Broan 30″ 300 CFM Under-Cabinet Range Hood – White|Hotte de cuisinière sous l’armoire 300 pi3/min Broan de 30 po – blanche|BCS330WW Image: Premium product showcase

Carefully crafted broan 30″ 300 cfm under-cabinet range hood – white|hotte de cuisinière sous l’armoire 300 pi3/min broan de 30 po – blanche|bcs330ww delivering superior performance and lasting value.

Key Features:

  • Industry-leading performance metrics
  • Versatile application capabilities
  • Robust build quality and materials
  • Satisfaction guarantee and warranty

🔗 View Product Details & Purchase

💡 Need Help Choosing? Contact our expert team for personalized product recommendations!

Remaining 0% to read
All articles, information, and images displayed on this site are uploaded by registered users (some news/media content is reprinted from network cooperation media) and are for reference only. The intellectual property rights of any content uploaded or published by users through this site belong to the users or the original copyright owners. If we have infringed your copyright, please contact us and we will rectify it within three working days.